Patient informed choice between palliative chemotherapy and best supportive care: who wants it?

Patient informed choice between palliative chemotherapy and best supportive care: who wants it? - Who wants to be fully informed?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30246

Enrollment

170

Registered

2006-08-24

Start date

2006-12-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with metastases

Interventions

The decision aid is delivered by a research nurse immediately after the visit with the medical oncologist, in which second line palliative chemotherapy is offered. The decision aid explains the two

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with distant metastases or loco-regional recurrence after primary breast or colon cancer are eligible, if they face the choice between second line palliative chemotherapy or best supportive care.

Exclusion criteria

Exclusion criteria: Exclusion criteria are labile personality structure, as assessed by the physicians, and a Karnofsky lower than 60.

Design outcomes

Primary

Measure	Time frame
Number of information items requested by the patient	—

Secondary

Measure	Time frame
Well-being and psychological variables related to decision making	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)